Consenso AEEH «Consenso sobre métodos de detección y derivación de enfermedades hepáticas prevalentes ocultas»-Reference-Cited by-同舟云学术

Consenso AEEH «Consenso sobre métodos de detección y derivación de enfermedades hepáticas prevalentes ocultas»

Published:2023-03 Issue:3 Volume:46 Page:236-247
ISSN:0210-5705
Container-title:Gastroenterología y Hepatología
language:es
Short-container-title:Gastroenterología y Hepatología

Author:

Romero-Gómez Manuel,Aller Rocío,Ampuero Javier,Fernández Rodríguez Conrado,Augustín Salvador,Latorre Raquel,Rivera-Esteban Jesús,Martínez Urroz Belén,Gutiérrez García María Luisa,López Sonia Alonso,Albillos Agustín,Hernández Marta,Graupera Isabel,Benlloch Salvador,Olveira Antonio,Crespo Javier,Calleja José Luis

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference79 articles.

1. High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study;Caballería;Clin Gastroenterol Hepatol.,2018

2. Miquel M, Clèries M, Vergara M, Vela E. BMJ Open. 2018; 8:e018012, https://doi.org/10.1136/bmjopen-2017-018012

3. The burden of liver disease in Europe: A review of available epidemiological data;Blachier;J Hepatol,2013

4. investigators of the LiverScreen Consortium Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe Asia;Serra-Burriel;Hepatol J,2019

5. Cost Effectiveness of Different Strategies for Detecting Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Based on United States Health Care System;Vilar-Gomez;Clin Gastroenterol Hepatol,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paciente con alteración del perfil hepático y factores de riesgo metabólico;Medicine - Programa de Formación Médica Continuada Acreditado;2024-03

2. Accuracy of a sequential algorithm based on FIB-4 and ELF to identify high-risk advanced liver fibrosis at the primary care level;Internal and Emergency Medicine;2023-11-11

3. Esteatosis hepática metabólica y nefropatía diabética: una llamada a la acción;Nefrología;2023-08

4. Concordance between non-invasive tests for the implementation of liver fibrosis screening algorithms in high-risk patients br;MED BALEAR;2023

5. Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key;International Journal of Molecular Sciences;2023-06-27